/Investor DB

Health Catalyst Capital — 2023 Investments

2 investments dated 2023 · listed companies and verified rows first · show all

Holmuskholmusk.cominSep 2023✓ verified

Holmusk builds real-world data and analytics products for neuropsychiatry, including NeuroBlu Data (de-identified patient records mapped from U.S. electronic health records) and NeuroBlu Analytics, an evidence engine that lets researchers build patient cohorts and run observational studies.

AI & Machine LearningData & InfrastructureDigital HealthMental HealthNew York, US

Nawal Roy(Founder)inTramontin Anthony David(Executive Officer, Director)Chik Wai Chiew(Director)Michael Weintraub(Director)

BoardVijay Prakash Barathan(Director)in

Board seatCharles Andrew Boorady· per SEC Form D

Co-investorsOptum VenturesNorthwell Holdings

Cylinder Healthvivantehealth.comin𝕏Sep 2023 · $31M

Vivante Health is a digital health company focused on gastrointestinal (GI) care, developing data-driven, value-based health programs and technology for managing digestive conditions.

Digital HealthHealthtechWellness & FitnessHouston, US

Kimon Angelides(Founder)inSally Welborn(Director)William Snyder(Executive Officer, Director)Marco Veremis(Director)inShawn Ellis(Director)inSanford Duncan(Director)

Co-investors7wire VenturesCorewell Health VenturesLifeforce CapitalMercato PartnersPeterson VenturesBig Pi Ventures+5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.